Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
MabVax Therapeutics Holdings, Inc. (MBVXQ) had Debt to Capital Ratio of 0.60 for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
$-32.79M |
|
-- |
|
-- |
|
$18.07M |
|
$-18.07M |
|
$-0.95M |
|
$-19.02M |
|
$-19.02M |
|
$-19.02M |
|
$-19.02M |
|
$-19.02M |
|
$-19.02M |
|
$-18.07M |
|
$-17.52M |
|
3.83M |
|
3.83M |
|
$-8.56 |
|
$-8.56 |
|
| Balance Sheet Financials | |
$1.21M |
|
$0.58M |
|
$7.58M |
|
$8.79M |
|
$5.81M |
|
$1.67M |
|
$1.85M |
|
$7.66M |
|
$1.12M |
|
$-5.70M |
|
$1.13M |
|
6.86M |
|
| Cash Flow Statement Financials | |
$-11.00M |
|
$-0.02M |
|
$7.92M |
|
$3.98M |
|
$0.89M |
|
$-3.09M |
|
$6.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.21 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.60 |
2.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1697.58% |
|
333.96% |
|
-216.38% |
|
-679.85% |
|
$0.16 |
|
$-2.88 |
|
$-2.87 |
|